Literature DB >> 4049608

Evaluation of the relative inhibitory potential of fractionated urinary macromolecules.

R Azoury, B Goldwasser, Y Wax, S Perlberg, N Garti, S Sarig.   

Abstract

UNLABELLED: Ultrafiltration membranes of 10,000 d, 1,000 d and 500 d were used to remove urinary macromolecules from the urine of normal subjects and from the urine of stone forming patients. The filtrated urines were examined for their residual inhibitory potential for calcium-oxalate precipitation, by the discrimination method of Sarig et al. (D.I. test). The results of testing the filtrate were complementary to the information gained by analyses of retentates obtained in successive ultrafiltration. The method has an inherent advantage because the manipulation of solids retained on membranes may inadvertantly modify their inhibitory potential. At least two distinct groups of inhibitors were found in 20 normal urines. The first group has MW above 10,000 d while the second group of inhibitors has MW in the range of 500-1,000 d. The mean of the D.I. values increased dramatically from the normal range (less than 0.6) to the stone former range (greater than 1.1) (p less than 0.001) after the 500 d filtration. Some of the normal urines, even after the 500 d filtration, still had a degree of inhibitory potential. This inhibitory potential may be related to the inorganic compounds which were found in the urines. The inhibitory activity of macromolecules with MW above 10,000 d and below 500 delta was negligible in 7 stone formers (SF) urines. The relative contribution of 500-1,000 d macromolecules is the highest both in SF and normal urines.
CONCLUSIONS: 1) inhibitors in human urine are of wide range in MW; 2) stone formers and normals differ in the level of inhibitor activity at all MW ranges; especially in above 10,000 d and below inhibitors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4049608     DOI: 10.1007/BF00261824

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  25 in total

1.  The urinary amino acids in relation to calculus disease.

Authors:  M G McGEOWN
Journal:  J Urol       Date:  1957-10       Impact factor: 7.450

2.  Biocolloids of urine in health and in calculous disease. II. Electrophoretic and biochemical studies of a mucoprotein insoluble in molar sodium chloride.

Authors:  W H BOYCE; M SWANSON
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808

3.  Inhibitory effects of urinary macromolecules on the crystallization of calcium oxalate.

Authors:  W B Gill; J W Karesh; L Garsin; M J Roma
Journal:  Invest Urol       Date:  1977-09

4.  A method for discrimination between calcium oxalate kidney stone formers and normals.

Authors:  S Sarig; N Garti; R Azoury; Y Wax; S Perlberg
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

5.  Isolation and characterization of calcium oxalate crystal growth inhibitors from human urine.

Authors:  Y Nakagawa; E T Kaiser; F L Coe
Journal:  Biochem Biophys Res Commun       Date:  1978-10-30       Impact factor: 3.575

6.  The mineralization inhibitory potential of urines: a constant composition approach.

Authors:  A C Lanzalaco; M E Sheehan; D J White; G H Nancollas
Journal:  J Urol       Date:  1982-10       Impact factor: 7.450

7.  Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine.

Authors:  H Ito; F L Coe
Journal:  Am J Physiol       Date:  1977-11

8.  May enzyme activity in urine play a role in kidney stone formation?

Authors:  R Azoury; N Garti; S Perlberg; S Sarig
Journal:  Urol Res       Date:  1982

9.  The paradox of inhibition and enhancement of the formation of urinary stones.

Authors:  G W Drach; S Sarig; A D Randolph; S Thorson
Journal:  Urol Res       Date:  1982

10.  The role of trace metals in calcium urolithiasis.

Authors:  J L Meyer; E E Angino
Journal:  Invest Urol       Date:  1977-03
View more
  6 in total

1.  Urinary crystal surface binding substances on calcium oxalate crystals.

Authors:  T Koide; T Yoshioka; S Yamaguchi; S Hosokawa; M Utsunomiya; T Sonoda
Journal:  Urol Res       Date:  1990

2.  The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine.

Authors:  M D Gohel; D K Shum; M K Li
Journal:  Urol Res       Date:  1992

3.  Hydration feature of urinary compounds. Evidence for molecular abnormality in calcium oxalate urolithiasis.

Authors:  R Azoury; J Ramon; S Abrashkin; J Shalev; B Goldwasser
Journal:  Urol Res       Date:  1990

4.  Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers.

Authors:  F Atmani; B Lacour; P Jungers; T Drüeke; M Daudon
Journal:  Urol Res       Date:  1994

5.  Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.

Authors:  F Atmani; B Lacour; T Drüeke; M Daudon
Journal:  Urol Res       Date:  1993-01

Review 6.  Urolithiasis--historical, comparative and pathophysiological aspects: a review.

Authors:  A R Michell
Journal:  J R Soc Med       Date:  1989-11       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.